Search

Your search keyword '"Paweł Balsam"' showing total 5 results
Start Over Author "Paweł Balsam" Publisher elsevier
5 results on '"Paweł Balsam"'

1. Clinical outcomes and predictors of long-term mortality, hemorrhagic and thromboembolic events in atrial fibrillation patients at different stages of chronic kidney disease: The CRAFT trial

Author

Marek Styczkiewicz, Mateusz Wawrzeńczyk, Michał Peller, Bartosz Krzowski, Cezary Maciejewski, Piotr Lodziński, Leszek Kraj, Grzegorz Opolski, Marcin Grabowski, and Paweł Balsam

Subjects
Atrial fibrillation, Bleeding, Chronic kidney disease, Ischemia, Survival, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Background Chronic kidney disease (CKD) coexisting with atrial fibrillation (AF) increases the risk of hemorrhage and ischemia. The study aimed to determine the relationship between different CKD stages and clinical outcomes of patients suffering from both CKD and AF and to determine the predictors of outcome. Methods The data was derived from multicenter CRAFT trial (NCT02987062). We have conducted a retrospective analysis of hospital records of 2663 AF patients divided in three groups according to their estimated glomerular filtration rate (eGFR) which was

Published
2023
Full Text
View/download PDF

2. Anemia at hospital admission and its relation to outcomes in patients with heart failure (from the polish cohort of 2 European Society of Cardiology Heart Failure Registries)

Author

Paweł Balsam, Michał Marchel, Agata Tymińska, Michał Peller, Aldo P. Maggioni, Ewa A. Jankowska, Grzegorz Opolski, Jarosław Drożdż, Agnieszka Kapłon-Cieślicka, Krzysztof Ozierański, María G. Crespo-Leiro, and Krzysztof J. Filipiak

Subjects
Male, Patient admission, medicine.medical_specialty, Survival rate, Anemia, Cardiology, Pilot Projects, Heart failure, Comorbidity, 030204 cardiovascular system & hematology, Risk Assessment, 03 medical and health sciences, Hemoglobins, Patient Admission, 0302 clinical medicine, Risk Factors, Cause of Death, Internal medicine, Prevalence, Humans, Medicine, Prospective Studies, 030212 general & internal medicine, Registries, Prospective cohort study, Societies, Medical, Aged, Retrospective Studies, Risk assessment, Heart Failure, business.industry, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Europe, Survival Rate, Clinical trial, Cohort, Female, Poland, Cardiology and Cardiovascular Medicine, business
Abstract

[Abstract] Anemia is a commonly observed co-morbidity in heart failure (HF). The aim of the study was to assess prevalence, risk factors for, and effect of anemia on short- and long-term outcomes in HF. The study included 1,394 Caucasian patients hospitalized for HF, with known hemoglobin concentration on hospital admission, participating in 2 HF registries of the European Society of Cardiology (Pilot and Long-Term). Anemia was defined as hemoglobin concentration of

Published
2017

3. Diagnosis, clinical course, and 1-year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry)

Author

Jarosław Drożdż, María G. Crespo-Leiro, Michalina Galas, Paweł Balsam, Michał Peller, Agnieszka Kapłon-Cieślicka, Grzegorz Opolski, Krzysztof Ozierański, Agata Tymińska, Aldo P. Maggioni, Michał Marchel, and Krzysztof J. Filipiak

Subjects
Male, Hospital mortality, Comorbidity, 030204 cardiovascular system & hematology, Severity of Illness Index, 0302 clinical medicine, immune system diseases, Atrial Fibrillation, Natriuretic Peptide, Brain, Prevalence, Hospital Mortality, Registries, 030212 general & internal medicine, Natriuretic peptides, Sleep apnea syndromes, Aged, 80 and over, Ejection fraction, Brain, Atrial fibrillation, Stroke volume, Middle Aged, respiratory system, Prognosis, Hospitalization, Echocardiography, Cohort, Hypertension, Disease Progression, Cardiology, Female, Cardiology and Cardiovascular Medicine, circulatory and respiratory physiology, medicine.medical_specialty, Heart failure, 03 medical and health sciences, Age Distribution, Sleep Apnea Syndromes, Internal medicine, Severity of illness, medicine, Humans, Sex Distribution, Aged, Heart Failure, Disease progression, business.industry, Stroke Volume, medicine.disease, respiratory tract diseases, Severity of illness index, Case-Control Studies, Poland, Heart failure with preserved ejection fraction, business
Abstract

[Abstract] Compared with heart failure (HF) with reduced ejection fraction (HF-REF), the diagnosis of HF with preserved EF (HF-PEF) is more challenging. The aim of the study was to assess the prevalence of HF-PEF among patients hospitalized for HF, to evaluate the pertinence of HF-PEF diagnosis and to compare HF-PEF and HF-REF patients with respect to outcomes. The analysis included 661 Polish patients hospitalized for HF, selected from the European Society of Cardiology (ESC)-HF Long-Term Registry. Patients with an EF of ≥50% were included in the HF-PEF group and patients with an EF of

Published
2016

5. Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMI – Randomized, control trial

Author

Łukasz Kołtowski, Krzysztof J. Filipiak, Janusz Kochman, Arkadiusz Pietrasik, Zenon Huczek, Pawel Balsam, Adam Lewandowski, Karolina Chojnacka, and Grzegorz Opolski

Subjects
acute coronary syndrome (ACS), costs, primary percutaneous coronary intervention (PCI), Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Introduction and objectives: Primary percutaneous coronary intervention infarction became the preferred method of treatment for myocardial ST segment elevation. Improved safety was reported in transradial access (radial) compared to transfemoral access (femoral). The aim of this study was to compare the cost between the two access points in ST segment elevation myocardial infarction. Methods: This is a subanalysis of the OCEAN RACE trial in which 103 myocardial infarction patients were randomized to either the radial (n=52) or femoral (n=51) groups. The clinical safety and efficacy were recorded during the hospital stay. The procedural metrics were meticulously logged, and costs were evaluated using the micro-cost method. The indirect costs were estimated using the human capital approach. Results: Clinical success was numerically higher in the radial group (90.4 vs. 80.4%, p=0.123). There were no differences in major adverse cardiac events (9.6% vs. 11.8%, p=0.48) and death (2.0% vs. 6.0%, p=0.31). The average in-hospital cost per patient was 2,740 ± 1,092 EUR. The cost of therapeutic success was lower in the radial group at 3,060 EUR vs. 3,374 EUR. The indirect costs related to absence at work were 138 EUR per patient, which were lower in the radial group compared to the femoral group. Conclusions: The total in-hospital costs were similar between the study groups. The indirect costs were lower in the radial group. Introduction of radial access as the default approach in all centers may significantly reduce the overall financial burden from a social perspective.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results